Katrina Adlerz, PhD, currently serves as a Senior Scientist at CTMC, a collaboration between Resilience and MD Anderson Cancer Center, since May 2022, focusing on analytics for cell therapy products and CMC authoring for INDs. Prior to this role, Katrina worked as a Scientist at MD Anderson Cancer Center from January 2021 to May 2022 and gained significant experience at RoosterBio Inc. from June 2017 to January 2021, where positions included Manager of Product Development and Senior Scientist in Product, Process, and Analytical Development, leading R&D strategy and product development related to stem cells and exosomes. Katrina holds a Ph.D. in Bioengineering and Biomedical Engineering from the University of Maryland and a Bachelor of Science in Biomedical Engineering from the University of Virginia.
This person is not in any offices
CTMC / A joint venture between Resilience + MD Anderson Cancer Center
Cell Therapy Manufacturing Center (CTMC) is a joint venture between Resilience and MD Anderson Cancer Center. CTMC was created to bring together the leading complex biologics manufacturing technology organization and the #1 clinical cancer center to enable innovation from academia and biotech to accelerate Cell Therapy’s impact for cancer patients.
Employees
51-200